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Purpose: We describe our experience with the Permacol graft in anophthalmic socket reconstruction, and com-
pare it to the autologous buccal mucosal graft, emphasizing the postoperative vascularization and contraction 
of each graft.
Methods: This was a retrospective comparative study. We measured the time necessary for the graft surface to 
be completely vascularized, as well as the fornix depth of the conjunctival sac in anophthalmic patients. 
Results: Ten patients underwent Permacol graft reconstruction, with 44 undergoing buccal mucosal graft recon-
struction. Seven eyelids (70%) in the Permacol group had a good outcome, with improvement in lower eyelid 
position and prosthesis retention. Nine out of 10 eyelids (90%) in this group showed complete vascularization 
of the graft at 2.6 ± 1.9 months postoperatively, while the grafted buccal mucosa was fully vascularized at 1.1 
± 0.3 months postoperatively (p < 0.01). Postoperative fornix depth in the Permacol group was 9.1 ± 2.2 mm, 
compared to 14.9 ± 4.5 mm in the buccal mucosal graft group (p < 0.01). Mean increases in fornix depth were 
33.1% and 67.9% of the mean vertical length of the implanted graft.
Conclusions: The Permacol graft can be useful as spacer graft material in anophthalmic socket patients. It 
takes longer to vascularize, and undergoes greater graft shrinkage with time, compared to the buccal mucosal 
graft.
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Socket contracture sometimes occurs in anophthalmic 
patients, and this results not only in a poor cosmetic out-
come, but also functional problems, such as ocular pros-
thesis displacement. To correct socket contracture, anterior 
lamellar repositioning or augmentation of the posterior 
lamella of the eyelid is usually required [1,2].
Current eyelid spacers include autogenous grafts, such 
as hard palate mucosal grafts. Allogeneic grafts include 
donor sclera or acellular human dermal graft (e.g., Allo-
Derm; LifeCell, The Woodlands, TX, USA), and synthetic 
implants include porous polyethylene. However, none of 
these substitutes are ideal as they are associated with dis-
advantages like donor site morbidity, risk of disease trans-
mission, and implant migration and extrusion.
Recently, a novel material derived from porcine acellular 
dermis (Enduragen; Tissue Science Laboratories, Alder-
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shot, UK) was described for use as a spacer graft in the 
eyelid. The study demonstrated a favorable outcome when 
the implant was used in the upper lid, lower lid, or as later-
al canthal reinforcement [3]. This porcine acellular dermis 
graft has also been marketed by Covidien (Dublin, Ireland) 
under a different name, Permacol. In this study, we would 
like to introduce our experience with the Permacol graft 
by comparing it to the autologous buccal mucosal graft. In 
particular, we would like to highlight and compare the 
postoperative vascularization and contraction that takes 
place with each graft over a 6-month period.
Materials and Methods
This was a retrospective comparative study of patients 
who underwent socket reconstructive surgery using the 
Permacol graft or autologous buccal mucosal graft as a 
spacer at Severance Hospital, Yonsei University from Jan-
uary 2011 to December 2012, by a single surgeon (JSY). 
Only patients with an anophthalmic socket, with at least 6 
months of follow-up after surgery were included. Medical 
records and clinical photographs of these patients were re-
viewed. Demographic data, follow-up duration, duration of 
prosthesis wear, cause of anophthalmos, risk factors for 
socket contracture, combined or further surgery, and com-
plications of surgery were tabulated. Operation records, 
including size of implanted graft, were also obtained. 
A good outcome was defined as an improvement in low-
er lid sagging with no prosthesis prolapse. A poor outcome 
was defined as no improvement in lower lid sagging that 
required further surgery with another type of spacer mate-
rial, the inability to fit a prosthesis, or prosthesis prolapse. 
The time necessary for the graft surface to be completely 
vascularized was assessed to evaluate the degree of fibro-
vascular integration of the graft. These were thoroughly 
assessed using a slit lamp microscope. The fornix depth of 
the conjunctival sac was directly measured using a ruler, 
after removal of the artificial eye. The calculated postoper-
ative fornix length was used to estimate immediate post-
operative fornix depth. It was computed as the sum of pre-
operative fornix depth and vertical length of the implanted 
graft.
The institutional review board of Yonsei University Col-
lege of Medicine, Seoul, Korea, approved this study. The 
study adhered to the tenets of the Declaration of Helsinki, 
and written informed consent was obtained from all par-
ticipants.
Surgical technique
A transconjunctival incision was made along the inferior 
border of the lower eyelid tarsus using monopolar cautery. 
Blunt dissection towards the orbital rim was performed 
without damaging the orbital septum. Upon reaching the 
orbital rim, an incision of the periosteum was made with a 
#15 blade, and an elevator was used to dissect the subperi-
osteal pocket to reach the infraorbital foramen. 
In the Permacol graft group, the implant was trimmed to 
the size of the defect. In the autologous buccal mucosal 
graft group, an ellipse of full-thickness mucosal graft was 
harvested from the inner aspect of the cheek. Care was 
taken to avoid Stenson’s duct adjacent to the upper second 
molar. Bosmin solution (epinephrine 1 mg/mL; Daiichi 
Sankyo, Tokyo, Japan) with 10% dilution application and 
electrocauterization were used at the donor site for hemo-
stasis, and the defect was packed with gel-form. The har-
vested graft was trimmed to size, and submucosal tissue 
was removed with scissors.
 The edges of the free graft were sutured to the sur-
rounding conjunctiva with interrupted 6-0 absorbable 
braided polyglactin sutures (Vicryl; Ethicon, Livingston, 
Fig. 1. The surgical procedure using the Permacol implant in 
anophthalmic socket reconstruction. (A) Intraoperative appear-
ance of Permacol implant. The implant edge is sutured to the con-
junctival edge. (B) External appearance of anophthalmic socket 
with fornix deepening sutures and retinal bolsters in place. (C) 
Appearance of graft at 1 week postoperatively. (D) Appearance 
of graft at 1 month postoperatively with superficial vasculariza-
tion.
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UK). A temporary traction suture was maintained for 3 
days postoperatively in all patients. Two double 5-0 
non-absorbable monof ilaments polyamide 6 (Nylon; 
WooRhi Medical, Namyangju, Korea) were used to anchor 
a silicone band bolster to deepen the inferior fornix. Each 
arm was passed through the silicone band and grafted mu-
cosa, the periosteum of the inferior orbital rim, and out 
through the lower eyelid. Retinal sponge bolsters were 
used for the skin. A conformer was inserted in the socket 
for at least 4 weeks postoperatively. The surgical technique 
is presented in Fig. 1A-1D. 
Statistical analysis
Patient characteristics, including age, duration of pros-
thesis wear, calculated fornix length, preoperative fornix 
depth, vertical length of implanted graft, and postoperative 
outcomes, including time to vascularization and postoper-
ative fornix depth were compared between the groups us-
ing the Mann-Whitney test. Preoperative and postoperative 
fornix depth in each group was compared using Wilcoxon 
signed-rank test. All statistical tests were two-sided with 
an α-level of 0.05, and were performed using SPSS Statis-
tics ver. 20.0. (IBM Co., Armonk, NY, USA).
Results
Permacol group
Ten patients underwent Permacol graft reconstruction. 
Patient demographics and clinical characteristics are de-
scribed in Table 1. The mean age was 38.2 years (range, 7 
to 69 years), with an equal number of males and females 
(Table 2). They were followed for 12.5 ± 4.9 months with 
an average duration of prosthesis wear of 24.4 years (range, 
1 to 55 years). The causes of anophthalmia were trauma (n 
= 3, 30%), congenital microphthalmia (n = 3, 30%), previ-
ous malignancy (n = 2, 20%), enucleation of eyeball after 
loss of vision by fever (n = 1, 10%), and unknown (n = 1, 
10%).
Seven patients (70%) were classified as having a good 
outcome due to improvement in the lower eyelid position 
with prosthesis retention (Fig. 2A-2D). Three patients (pa-
tients 1, 8, and, 10) had a poor outcome. Two of these pa-
tients (patients 1 and 10) had persistent socket inflamma-
tion with recurrent socket contracture, requiring a second 
fornix deepening procedure with oral mucosal grafting. 
One patient (patient 8) was unable to retain an ocular pros-
thesis at the end of the follow-up period, despite a deep-
ened fornix. 
Nine out of 10 eyelids showed complete vascularization 
of the graft within 2 to 2.5 months of surgery (Fig. 3A). In 
one case (patient 5), the Permacol graft in the remaining 
eyelid did not vascularize well even at 8 months postoper-
atively (Fig. 3B). However, the unvascularized remnant is-
lands were completely excised without complications.
The mean preoperative fornix depth was 4.4 ± 2.5 mm. 
The postoperative fornix depth at 1 month postoperatively 
was 11.4 ± 2.6 mm (p < 0.01), though this became shallow-
er at 9.1 ± 2.2 mm (p < 0.01) at postoperative 6 months. 
Autologous buccal mucosal graft group
Patient ages ranged from 10 to 79 years with a mean age 
of 45.9 years, 17 patients (38.6%) were male (Table 2). The 
mean follow-up period was 8.4 months after the recon-
Fig. 3. Conjunctivalization of the Permacol graft. (A) Good out-
comes showing complete vascularization of the Permacol graft. 
(B) Poor vascularization of the Permacol graft at 8 months post-
operatively, showing unvascularized islands.
Fig. 2. Representative patients in preoperative (left) and post-
operative (right) photographs, who underwent reconstructive 
surgery with the Permacol graft. Photographs of adult (A,B) and 
pediatric (C,D) anophthalmic socket patients.
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structive surgery. Patients used an ocular prosthesis for an 
average of 15.6 years. The causes of anophthalmos includ-
ed trauma (24 patients), tumor (five patients), congenital 
anomalies such as microphthalmos or anophthalmos (eight 
patients), and other disorders causing phthisis (e.g., retinal 
detachment, glaucoma, and uveitis) (seven patients).
In this group, 14 had severe socket contraction prior to 
the surgery; two had history of radiotherapy before enu-
cleation for tumors; nine had previous complicated implant 
surgeries (e.g., exposure, infection, or small implant); three 
had a previous peg insertion; and two had prolonged sock-
et inflammation for more than 1 month after socket recon-
struction surgery.
The grafted buccal mucosa was fully vascularized ap-
proximately 1 month after surgery (mean ± standard devi-
ation, 1.1 ± 0.3 months). At preoperative and postoperative 
6 months, fornix depths were 5.8 ± 2.4 and 14.9 ± 4.5 mm, 
respectively (p < 0.01).
Comparison between Permacol and autologous buccal 
mucosal graft groups
Age, sex, and duration of prosthesis wear were not sig-
nificantly different between the two groups (Table 2). The 
Permacol graft took significantly longer (2.6 ± 1.9 months) 
to vascularize, compared to the buccal mucosal graft (1.1 ± 
0.3 months) ( p < 0.01). The preoperative fornix depths 
were not statistically different, as was the vertical length 
of the implanted graft (p = 0.274 and p = 0.573, respective-
ly). The calculated postoperative fornix length did not dif-
fer between the groups (p = 0.274). In contrast, the fornix 
depth in the Permacol group was significantly shorter 9.1 ± 
2.2 mm at the end of the follow-up period, compared to the 
fornix depth in the buccal mucosal graft group 14.9 ± 4.5 
mm (p < 0.01) (Fig. 4). Mean increases in fornix depth af-
ter surgery were 4.4 mm and 9.1 mm, and they correspond-
ed with 33.1% and 67.9% of the mean vertical lengths of 
the implanted graft, respectively.
Discussion
The Permacol surgical implant is a bioengineered, por-
cine-derived dermal collagen implant, from which cells 
are removed in a gentle process to reduce immunogenicity. 
The resulting acellular collagen matrix is then cross-linked 
for enhanced durability, which allows the formation of 
new collagen in the matrix. Permacol was first described 
in the literature for use in reconstructive hand surgery [4]. 
More recently, it has been used in the repair of abdominal 
wall defects [5], orbital fractures [6], and eyelid recon-
structions [3,7].
Table 2. Comparison of clinical variables between Permacol and buccal mucosa groups
Permacol group Buccal mucosa group p-value
Age (yr) 38.2 ± 18.1 45.9 ± 17.5 0.216
Male    5 (50)     17 (38.6) 0.723
Duration of prosthesis wear (yr) 24.4 ± 18.0 15.6 ± 15.1 0.139
Calculated postoperative fornix length (mm) 18.6 ± 1.2 19.1 ± 1.1 0.274
Preoperative fornix depth 4.4 ± 2.5 5.8 ± 2.4 0.274
Vertical length of implanted graft 14.2 ± 3.2 13.4 ± 1.9 0.573
Values are presented as mean ± standard deviation or number (%).
*
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Fig. 4. Comparison of preoperative (preop) and postoperative 
(postop) fornix depth in anophthalmic socket patients receiving 
Permacol and undergoing buccal mucosal graft reconstructive 
surgery. *p < 0.05, both groups.
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McCord et al. [3] have described a porcine acellular der-
mal collagen matrix manufactured by Tissue Science Lab-
oratories as spacer material for the reconstruction of the 
upper and lower eyelid, as well as for lateral canthal sus-
pension surgery.
To our knowledge, this is the first study to examine the 
clinical characteristics, as well as the vascularization and 
contracture of the Permacol graft, in detail in context of 
implantation in the lower eyelid as spacer material in 
anophthalmic socket reconstruction. We chose to compare 
it with buccal mucosal tissue, which is the preferred lower 
eyelid spacer material in our practice for anophthalmic 
socket reconstruction.
One major advantage of Permacol is that it is readily 
available to the surgeon and does not inflict any donor site 
morbidity. Since there is no need to harvest any donor tis-
sue and the tissue does not require hydration prior to use, 
surgical time is reduced. The buccal mucosal graft, on the 
other hand, results in donor site morbidity, patient discom-
fort and prolongs surgical time as a result of donor har-
vesting [8,9]. One possible disadvantage of Permacol is 
that, like other xenografts (e.g., Tarsys), it may carry with 
it a potential risk of allergic reaction and inf lammation 
[10,11], though this was not encountered in our study popu-
lation. It has also been reported to elicit a chronic granulo-
matous reaction, similar to a foreign body reaction, when 
implanted in the orbit for orbital floor fracture repair [6]. 
The buccal mucosal graft, on the other hand, is an autoge-
nous source, and hence avoids the risk of tissue rejection 
and disease transmission.
In our clinical trial, the Permacol graft provided a good 
clinical outcome in seven out of 10 patients. The poor out-
come in two patients was attributed to persistent socket in-
f lammation with recurrent socket contracture. The third 
patient had a poor outcome despite a deepened fornix due 
to multiple factors, such as like facial nerve palsy, trau-
matic blow in fracture of the orbit, and absent orbital im-
plant, which made prosthesis fitting impossible. The Per-
macol graft was completely vascularized in nine out of 10 
patients within 2.5 months. This is not surprising, as the 
vascularization process of the implanted porcine acellular 
dermis graft has been demonstrated to take place as early 
as the third postoperative day in rat models [12]. However, 
vascularization of the graft was poor in one patient (patient 
5). It is possible that vascularization is dependent on the 
surface area in contact with the host conjunctival tissue, as 
demonstrated in human acellular dermis grafts [13]. Any 
local host tissue factors that interfere with this interaction 
could affect the vascularization of the graft (e.g., an unde-
tected hematoma, graft slippage, infection, or an irradiated 
socket with poor vascular supply). Systemic conditions like 
poorly controlled diabetes with poor wound healing re-
sponse may also affect the vascularization of the graft. 
The duration to vascularization in the Permacol group was 
significantly longer than in the buccal mucosal group. Ani-
mal histologic studies have shown that small vessels and 
inflammatory cells are present up to 5 weeks after implan-
tation [14], suggesting that the host remodeling response is 
ongoing at this stage. This delay in vascularization could 
be attributed to delayed host cell recognition of the acellu-
lar xenograft, in contrast with an autogenous buccal muco-
sal graft.
In this study, direct measurement of the immediate post-
operative fornix depth could not be completed due to post-
operative discomfort. Instead, we used the calculated post-
operative fornix length to estimate it. The calculated 
postoperative fornix length is computed as the sum of the 
preoperative fornix depth and the vertical length of the 
grafted material, but is not the actual postoperative fornix 
depth because the angulation of the fornix was formed on 
graft material, duplicating the graft length in the fornix; in 
other words, the actual fornix depth may be shorter than 
the calculated fornix length. However, the calculated for-
nix length was not statistically different between the two 
groups, and a fornix depth difference at 6 months after 
surgery implies clinical significance.
The authors feel that Permacol is not as effective as buc-
cal mucosal graft as a fornix-deepening spacer material. 
There was an improvement in fornix depth in the Perma-
col group, but the improvement was significantly less than 
that afforded by the buccal mucosa group. This is most 
likely due to fibrosis and contraction of the Permacol graft 
over time. Significant graft shrinkage of the porcine acel-
lular dermal matrix was noted in the in vivo rat model [14]. 
Graft shrinkage of the acellular human dermis graft has 
previously been described [15-17], with resorption appear-
ing to be a primary disadvantage. The rate and occurrence 
of resorption is unpredictable, and has been suggested to 
be due to inadequate exposure to vascular tissue and dehy-
dration [13]. It seems likely that the porcine acellular der-
mis graft undergoes a similar process of fibrosis, contrac-
tion, and resorption. As such, the authors recommend 
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oversizing the Permacol graft intraoperatively, in order to 
account for graft shrinkage over time.
The limitations of this study are its retrospective design 
and limited duration of follow-up. It also has a small sam-
ple size, and reflects only a single surgeon’s experience.
In summary, the Permacol graft can be a useful spacer 
graft material in patients with anophthalmic sockets. Care-
ful selection of patients with no risk factors for recurrent 
socket contracture and poor vascularization is important. 
Meticulous surgical technique will optimize the surgical 
outcome, and oversizing the graft intraoperatively will 
help to compensate for postoperative graft shrinkage. 
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